My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Various WA Local Governments 9/21/2022
>
Contracts
>
Agreement
>
Interlocal Agreements
>
Various WA Local Governments 9/21/2022
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/26/2024 7:10:18 AM
Creation date
9/30/2022 2:40:54 PM
Metadata
Fields
Template:
Contracts
Contractor's Name
Various WA Local Governments
Approval Date
9/21/2022
Council Approval Date
9/14/2022
Department
Legal
Department Project Manager
Ramsey Ramerman
Subject / Project Title
Settlement Agreement Opioid Distributors
Tracking Number
0003472
Total Compensation
$0.00
Contract Type
Agreement
Contract Subtype
Interlocal Agreements
Retention Period
6 Years Then Destroy
Imported from EPIC
No
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
149
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
OPIOID ABATEMENT STRATEGIES <br /> PART ONE: TREATMENT <br /> A. TREAT OPIOID USE DISORDER(OUD) <br /> Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use <br /> Disorder or Mental Health (SUD/MH) conditions, co-usage, and/or co-addiction through <br /> evidence-based, evidence-informed, or promising programs or strategies that may include, <br /> but are not limited to,the following: <br /> 1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, <br /> co-usage, and/or co-addiction, including all forms of Medication-Assisted Treatment <br /> (MAT) approved by the U.S. Food and Drug Administration. <br /> 2. Support and reimburse services that include the full American Society of Addiction <br /> Medicine (ASAM) continuum of care for OUD and any co-occurring SUD/MH <br /> conditions, co-usage, and/or co-addiction, including but not limited to: <br /> a. Medication-Assisted Treatment (MAT); <br /> b. Abstinence-based treatment; <br /> c. Treatment, recovery, or other services provided by states, subdivisions, <br /> community health centers; non-for-profit providers; or for-profit providers; <br /> d. Treatment by providers that focus on OUD treatment as well as treatment by <br /> providers that offer OUD treatment along with treatment for other SUD/MH <br /> conditions, co-usage, and/or co-addiction; or <br /> e. Evidence-informed residential services programs,as noted below. <br /> 3. Expand telehealth to increase access to treatment for OUD and any co-occurring <br /> SUD/MH conditions, co-usage, and/or co-addiction, including MAT, as well as <br /> counseling, psychiatric support, and other treatment and recovery support services. <br /> 4. Improve oversight of Opioid Treatment Programs (OTPs) to assure evidence-based, <br /> evidence-informed, or promising practices such as adequate methadone dosing. <br /> 5. Support mobile intervention, treatment, and recovery services, offered by qualified <br /> professionals and service providers, such as peer recovery coaches, for persons with <br /> OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction and <br /> for persons who have experienced an opioid overdose. <br /> 6. Support treatment of mental health trauma resulting from the traumatic experiences of <br /> the opioid user(e.g., violence, sexual assault, human trafficking, or adverse childhood <br /> experiences) and family members (e.g., surviving family members after an overdose <br /> 1 <br />
The URL can be used to link to this page
Your browser does not support the video tag.